Psychedelics Recent News

Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Russell Newcombe Dies - Legacy Of UK's Longtime Harm Reduction Advocate, Committed Drug Researcher
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
At 77, Cannabis Champion Dana Beal Fights Idaho Laws To Push Legalization In Hostile Territory